Last reviewed · How we verify

NCT03751644

Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies

Completed NA Last updated 30 April 2021
What this trial tests

NA trial testing Electrical stimulation in Electrical Remodeling in 6 participants. Completed in 29 April 2021.

Timeline
1 November 2018
Primary endpoint
29 April 2021
29 April 2021

Quick facts

Lead sponsorUniversity of Sao Paulo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment6
Start date1 November 2018
Primary completion29 April 2021
Estimated completion29 April 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo

Who can join

Adults 18 to 80, any sex, with Electrical Remodeling or Rheumatic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases with progressive skeletal muscle weakness. The relevance of the peripherical neuromuscular electrical stimulation has never applied in the patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, investigator-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of an acute peripherical neuromuscular electrical stimulation session in patients with systemic autoimmune myopathies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Electrical stimulation

Trials testing the same drug.

Other University of Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03751644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing